JPRN-UMIN000051442招募中Unknown
The renal benefits of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study - Kushiro T2DCKD-TZP long-term study
Kushiro Red Cross Hospital0 个研究点目标入组 50 人开始时间: 2023年6月25日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects on erythropoietin stimulating agents or hypoxia-inducible factor-prolyl hydroxylase domain inhibitor 2) Subjects on maintenance hemodialysis or peritoneal dialysis 3) Subjects who are deemed to be unsuitable by the investigator
研究者
相似试验
招募中
Unknown
The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational studyType 2 diabetesJPRN-UMIN000051344Kushiro Red Cross Hospital50
进行中（未招募）
1 期
Tirzepatide Mechanism of Action Study on Renal Function (TREASURE-CKD)EUCTR2021-005273-47-NLEli Lilly and Company140
进行中（未招募）
1 期
Tirzepatide Mechanism of Action Study on Renal Function (TREASURE-CKD)Obesity and Chronic Kidney diseaseMedDRA version: 20.0Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2021-005273-47-DKEli Lilly and Company140
招募中
2 期
Tirzepatide Study of Renal Function in People with Overweight or Obesity and Chronic Kidney Disease with or without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease using Multiparametric Magnetic Resonance Imaging (TREASURE-CKD)NL-OMON51386Eli Lilly16
进行中（未招募）
1 期
Tirzepatide Mechanism of Action Study on Renal Function (TREASURE-CKD)Obesity and Chronic Kidney diseaseMedDRA version: 20.0Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2021-005273-47-ATEli Lilly and Company140